Lastly, we monitored SUMOylation in SPRTN-mutated cells from a Ruijs-Aalfs syndrome (RJALS) patient (Lessel et al., 2014). This evidence concerns the gene SPRTN and progeroid features-hepatocellular carcinoma predisposition syndrome.